Immunosuppressants protein tyrosine kinase Neuronal Signaling PI3K / Akt / mTOR Metabolism Cell Cycle Epigenetics Cytoskeletal Signaling Angiogenesis DNA damage Proteases Apoptosis Mitogen-activated protein kinase (MAPK) Endocrinology & Hormones GPCR & G Protein Transmembrane Transporters Protein tyrosine kinase /JAK / STAT TGF-beta / Smad Stem Cells & Wnt Nuclear transcription factor (NF-κB) Ubiquitin Microbiology Autophagy
ChemicalBook >   Product Catalog >  Biochemical Engineering >  Inhibitors

Inhibitors

Immunosuppressants protein tyrosine kinase Neuronal Signaling PI3K / Akt / mTOR Metabolism Cell Cycle Epigenetics Cytoskeletal Signaling Angiogenesis DNA damage Proteases Apoptosis Mitogen-activated protein kinase (MAPK) Endocrinology & Hormones GPCR & G Protein Transmembrane Transporters Protein tyrosine kinase /JAK / STAT TGF-beta / Smad Stem Cells & Wnt Nuclear transcription factor (NF-κB) Ubiquitin Microbiology Autophagy
More
Less

Inhibitor refers to substance that can hinder the chemical reactions, biological reactions (including immune response) and biological activity. In present time, commonly used inhibitors include immunosuppressants and inhibitors.

1. Immunosuppressive agents: immunosuppressants system refers to drug that can reduce the immune response. It can selectively suppress certain steps of the immune response and immune cells. Immune response refers to the body’s response to a variety of pathogenic substances. Some reactions are favorable to the body and can enhance the body's resistance to disease; some have adverse effects on the body and can cause tissue damage or disorders of physiological functions (allergy). Therefore, patients suffering from allergic reactions being harmful to the body should be subject to the treatment of immunosuppressant to affect the related immune processes and reduce the immune response of the body.

For the treatment of various autoimmune diseases and weakening the tissue incompatibility, it has been developed of a variety of immunosuppressive agents, some of which have been widely used in clinical practice. Commonly used immunosuppressants include glucocorticoids (prednisone, prednisolone, etc.), alkylating agents (nitric oxide mustard, cyclophosphamide, thiotepa, busulfan, etc.), and antimetabolites (6- mercaptopurine, azathioprine, methotrexate, etc.).

The mechanism of immunosuppressants, though not entirely clear, but is characterized by the following several aspects:
① most kinds of immunosuppressants can simultaneously inhibit cellular and humoral immunity and can be used for organ transplantation and autoimmune disease.
②Its inhibitory effect is strong for the primary immune response while the inhibitory effect against secondary response is weak.
③It can simultaneously act on normal and pathological immunity, therefore, can often lead to some complications.
④These drugs often have strong with serious adverse reactions.

2. Enzyme inhibitors: Enzyme inhibitors refer to compounds or drugs being capable of binding to enzyme and inhibit the enzymatic activity. It is clinically often applied of enzyme inhibitors to specially interfere with certain metabolic system to achieve the therapeutic purposes. For example, people use monoamine oxidase inhibitors as antidepressants; use carbonic anhydrase inhibitors as diuretics; use dopa decarboxylase inhibitors as antihypertensive drugs and use antibiotics such as penicillin, cephalosporins belonging to cell wall synthesis inhibitors. Enzyme inhibitors have applications in veterinary medicine and agriculture. In addition, people can also apply enzyme inhibitors to study the mechanism of the enzyme and metabolic pathways.

Enzyme inhibitors often have similar structure with their natural substrates. For designing the inhibitors according modification of natural substrate, people should first analyze and decide the function of each part of the molecule in binding with enzymes: for binding or not binding or repulsion; secondly, people should know the degree of tolerance of the binding site to the adjacent steric hindrance. Then people can replace each functional group to regulate the strength of interaction with the enzyme.

Inhibitors can be divided into reversible and irreversible, two classes. (1)Inhibitors binding with enzyme through non-covalent bonds are called reversible inhibitor. (2)Inhibitors binding to the enzyme via a covalent bond are irreversible inhibitors with strong binding affinity. They will not be affected by concentration change process such as dialysis or dilution after binding to the enzyme.

Click on the specific product, view the latest prices of the products, information, serving information

Structure:
Chemical Name:
GNF 5837
CAS:
1033769-28-6
MF:
C28H21F4N5O2
Structure:
Chemical Name:
AZD2461
CAS:
1174043-16-3
MF:
C22H22FN3O3
Structure:
Chemical Name:
5-[[4-(4-Pyridinyl)-6-quinolinyl]methylene]-2,4-thiazolidenedione
CAS:
958852-01-2
MF:
C18H11N3O2S
Structure:
Chemical Name:
N-(4-Chloro-3-methoxyphenyl)-2-pyridinecarboxamide
CAS:
1161205-04-4
MF:
C13H11ClN2O2
Structure:
Chemical Name:
Aurora A Inhibitor I
CAS:
1158838-45-9
MF:
C31H31ClFN7O2
Structure:
Chemical Name:
AMG 458
CAS:
913376-83-7
MF:
C30H29N5O5
Structure:
Chemical Name:
GSK461364
CAS:
929095-18-1
MF:
C27H28F3N5O2S
Structure:
Chemical Name:
(E)-N-[4-(1-BENZOYL-PIPERIDIN-4-YL)-BUTYL]-3-PYRIDIN-3-YL-ACRYLAMIDE
CAS:
658084-64-1
MF:
C24H29N3O2
Structure:
Chemical Name:
2-[[(2E)-3-(2-NAPHTHALENYL)-1-OXO-2-BUTEN-1-YL]AMINO]BENZOIC ACID
CAS:
321674-73-1
MF:
C21H17NO3
Structure:
Chemical Name:
FH 535
CAS:
108409-83-2
MF:
C13H10Cl2N2O4S
Structure:
Chemical Name:
ARRY-380
CAS:
937265-83-3
MF:
C29H27N7O4S
Structure:
Chemical Name:
SteMRegenin 1
CAS:
1227633-49-9
MF:
C24H23N5OS
Structure:
Chemical Name:
CX-5461
CAS:
1138549-36-6
MF:
C27H27N7O2S
Structure:
Chemical Name:
GSK 2334470
CAS:
1227911-45-6
MF:
C25H34N8O
Structure:
Chemical Name:
7Methyl-5-(1-{[3-(trifluoroMethyl)phenyl]acetyl}-2,3-dihydro1Hindol-5-yl)7Hpyrrolo[2,3d]pyriMidin-4-aMine
CAS:
1337531-36-8
MF:
C24H20F3N5O
Structure:
Chemical Name:
PHT-427
CAS:
1191951-57-1
MF:
C20H31N3O2S2
Structure:
Chemical Name:
MK-5108 (VX-689)
CAS:
1010085-13-8
MF:
C22H21ClFN3O3S
Structure:
Chemical Name:
N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine
CAS:
1097917-15-1
MF:
C29H40N8O3S
Structure:
Chemical Name:
EUK 134
CAS:
81065-76-1
MF:
C18H18ClMnN2O4
Structure:
Chemical Name:
1-AZAKENPAULLONE
CAS:
676596-65-9
MF:
C15H10BrN3O
Structure:
Chemical Name:
Tasisulam
CAS:
519055-62-0
MF:
C11H6BrCl2NO3S2
Structure:
Chemical Name:
IGF-1R Inhibitor II, N-(5-Chloro-2-methoxyphenyl)-Nμ-(2-methylquinolin-4-yl)urea
CAS:
196868-63-0
MF:
C18H16ClN3O2
Structure:
Chemical Name:
2-[[(1R)-1-[7-methyl-2-(4-morpholinyl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid
CAS:
1173900-33-8
MF:
C22H24N4O4
Structure:
Chemical Name:
5-[3-Methoxy-4-(4-methoxy-benzyloxy)-benzyl]-pyrimidine-2,4-diamine
CAS:
870483-87-7
MF:
C20H22N4O3
Structure:
Chemical Name:
1-{2-[5-(2-Methoxy-ethoxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine
CAS:
343787-29-1
MF:
C24H27N5O2
Structure:
Chemical Name:
YK-4-279
CAS:
1037184-44-3
MF:
C17H13Cl2NO4
Structure:
Chemical Name:
2,2'-[[Dihydro-2-(4-pyridinyl)-1,3(2H,4H)-pyrimidinediyl]bis(methylene)]bis[N,N-dimethylbenzenamine
CAS:
500579-04-4
MF:
C27H35N5
Structure:
Chemical Name:
NVP-BHG712
CAS:
940310-85-0
MF:
C26H20F3N7O
Structure:
Chemical Name:
Imidazo[4,5,1-jk][1,4]benzodiazepin-7(4H)-one, 2-[4-[(dimethylamino)methyl]phenyl]-5,6-dihydro-
CAS:
328543-09-5
MF:
C19H20N4O
Structure:
Chemical Name:
BMS707035
CAS:
729607-74-3
MF:
C17H19FN4O5S
Structure:
Chemical Name:
Tepotinib
CAS:
1100598-32-0
MF:
C29H28N6O2
Structure:
Chemical Name:
[4-[2-(1H-Indazol-3-yl)ethenyl]phenyl]-1-piperazinylmethanone
CAS:
1000669-72-6
MF:
C20H20N4O
Structure:
Chemical Name:
CCT 137690
CAS:
1095382-05-0
MF:
C26H31BrN8O
Structure:
Chemical Name:
KW-2478
CAS:
819812-04-9
MF:
C30H42N2O9
Structure:
Chemical Name:
U0126-EtOH
CAS:
1173097-76-1
MF:
C20H22N6OS2
Structure:
Chemical Name:
SCH900776
CAS:
891494-63-6
MF:
C15H18BrN7
Structure:
Chemical Name:
GSK1838705A
CAS:
1116235-97-2
MF:
C27H29FN8O3
Structure:
Chemical Name:
BML-275
CAS:
1219168-18-9
MF:
C24H27Cl2N5O
Structure:
Chemical Name:
TAK-285
CAS:
871026-44-7
MF:
C26H25ClF3N5O3
Structure:
Chemical Name:
CZC24832
CAS:
1159824-67-5
MF:
C15H17FN6O2S
Structure:
Chemical Name:
MLN0905
CAS:
1228960-69-7
MF:
C24H25F3N6S
Structure:
Chemical Name:
MGluR5 inhibitor
CAS:
871362-31-1
MF:
C19H13ClF3N3O
Structure:
Chemical Name:
XL765
CAS:
1349796-36-6
MF:
C31H29N5O6S
Structure:
Chemical Name:
ETP46464
CAS:
1345675-02-6
MF:
C30H22N4O2
Structure:
Chemical Name:
AZD 1080
CAS:
612487-72-6
MF:
C19H18N4O2
Structure:
Chemical Name:
UNC-1215
CAS:
1415800-43-9
MF:
C32H43N5O2
Structure:
Chemical Name:
LCZ696
CAS:
936623-90-4
MF:
C48H58N6O8
Structure:
Chemical Name:
Stattic
CAS:
19983-44-9
MF:
C8H5NO4S
Structure:
Chemical Name:
Fenspiride hydrochloride
CAS:
5053-08-7
MF:
C15H21ClN2O2
Structure:
Chemical Name:
SB 415286
CAS:
264218-23-7
MF:
C16H10ClN3O5
Structure:
Chemical Name:
GO 6983
CAS:
133053-19-7
MF:
C26H26N4O3
Structure:
Chemical Name:
6-AMINO-4-(4-PHENOXYPHENYLETHYLAMINO)QUINAZOLINE
CAS:
545380-34-5
MF:
C22H20N4O
Structure:
Chemical Name:
JNJ7777120
CAS:
459168-41-3
MF:
C14H16ClN3O
Structure:
Chemical Name:
SC-514
CAS:
354812-17-2
MF:
C9H8N2OS2
Structure:
Chemical Name:
3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione
CAS:
905854-02-6
MF:
C23H19N3O2
Structure:
Chemical Name:
4-[(2,6-dichlorobenzoyl)amino]-N-4-piperidinyl1H-pyrazole-3-carboxamide
CAS:
844442-38-2
MF:
C16H17Cl2N5O2
Structure:
Chemical Name:
3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol
CAS:
677297-51-7
MF:
C18H14N6O2
Structure:
Chemical Name:
PD173955
CAS:
260415-63-2
MF:
C21H16Cl2N4OS
Structure:
Chemical Name:
ADL-5859
CAS:
850173-95-4
MF:
C24H29ClN2O3
Structure:
Chemical Name:
GDC-0941 Bimesylate
CAS:
957054-33-0
MF:
C24H30N7O6S3
Structure:
Chemical Name:
LY2228820
CAS:
862507-23-1
MF:
C26H37FN6O6S2
Structure:
Chemical Name:
IWR-1-endo
CAS:
1127442-82-3
MF:
C25H19N3O3
Structure:
Chemical Name:
N-[3-[4,5-Dihydro-4-methyl-6-[[4-(4-morpholinylcarbonyl)phenyl]amino]-5-oxo-2-pyrazinyl]-2-methylphenyl]-4-(tert-butyl)benzamide
CAS:
910232-84-7
MF:
C34H37N5O4
Structure:
Chemical Name:
AR-42
CAS:
935881-37-1
MF:
C18H20N2O3
Structure:
Chemical Name:
CCT128930
CAS:
885499-61-6
MF:
C18H20ClN5
Structure:
Chemical Name:
AMG 900
CAS:
945595-80-2
MF:
C28H21N7OS
Structure:
Chemical Name:
SGI-1776
CAS:
1025065-69-3
MF:
C20H22F3N5O
Structure:
Chemical Name:
WP1130
CAS:
856243-80-6
MF:
C19H18BrN3O
Structure:
Chemical Name:
Binimetinib
CAS:
606143-89-9
MF:
C17H15BrF2N4O3
Structure:
Chemical Name:
Icotinib
CAS:
610798-31-7
MF:
C22H21N3O4
Structure:
Chemical Name:
WP1066
CAS:
857064-38-1
MF:
C17H14BrN3O
Structure:
Chemical Name:
PACRITINIB
CAS:
937272-79-2
MF:
C28H32N4O3
Structure:
Chemical Name:
Tazemetostat (EPZ-6438)
CAS:
1403254-99-8
MF:
C34H44N4O4
Structure:
Chemical Name:
PluriSln 1
CAS:
91396-88-2
MF:
C12H11N3O
Structure:
Chemical Name:
Glasdegib
CAS:
1095173-27-5
MF:
C21H22N6O
Structure:
Chemical Name:
3,4-Dichloro-N-(1-Methylbutyl)benza-Mide
CAS:
7497-07-6
MF:
C12H15Cl2NO
Structure:
Chemical Name:
NMS 873
CAS:
1418013-75-8
MF:
C27H28N4O3S2
Structure:
Chemical Name:
NU7026
CAS:
154447-35-5
MF:
C17H15NO3
Structure:
Chemical Name:
4-METHYL-N1-(3-PHENYLPROPYL)BENZENE-1,2-DIAMINE
CAS:
749886-87-1
MF:
C16H20N2
Structure:
Chemical Name:
(-)-Blebbistatin
CAS:
856925-71-8
MF:
C18H16N2O2
Structure:
Chemical Name:
4-(4-FLUORO-1-NAPHTHALENYL)-6-(1-METHYLETHYL)-2-PYRIMIDINAMINE HYDROCHLORIDE
CAS:
199864-87-4
MF:
C17H16FN3
Structure:
Chemical Name:
LY-404039
CAS:
635318-11-5
MF:
C7H9NO6S
Structure:
Chemical Name:
Plinabulin(NPI-2358)
CAS:
714272-27-2
MF:
C19H20N4O2
Structure:
Chemical Name:
PHA-848125
CAS:
802539-81-7
MF:
C25H32N8O
Structure:
Chemical Name:
Safinamide mesylate
CAS:
202825-46-5
MF:
C17H19FN2O2.CH4O3S
Structure:
Chemical Name:
3-(1H-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione
CAS:
425637-18-9
MF:
C25H22N6O2
Structure:
Chemical Name:
WYE-354
CAS:
1062169-56-5
MF:
C24H29N7O5
Structure:
Chemical Name:
CP466722
CAS:
1080622-86-1
MF:
C17H15N7O2
Structure:
Chemical Name:
LY2603618
CAS:
911222-45-2
MF:
C18H22BrN5O3
Structure:
Chemical Name:
5-(4-aMino-1-isopropyl-1H-pyrazolo[3,4-d]pyriMidin-3-yl)benzo[d]oxazol-2-aMine
CAS:
1224844-38-5
MF:
C15H15N7O
Structure:
Chemical Name:
OMecaMtiv Mecarbil
CAS:
873697-71-3
MF:
C20H24FN5O3
Structure:
Chemical Name:
PIK-75 Hydrochloride
CAS:
372196-77-5
MF:
C16H15BrClN5O4S
Structure:
Chemical Name:
Capmatinib
CAS:
1029712-80-8
MF:
C23H17FN6O
Structure:
Chemical Name:
EPZ004777
CAS:
1338466-77-5
MF:
C28H41N7O4
Structure:
Chemical Name:
KY0211
CAS:
1118807-13-8
MF:
C18H17ClN2O3S
Structure:
Chemical Name:
IWP L6
CAS:
1427782-89-5
MF:
C25H20N4O2S2
Structure:
Chemical Name:
KI16425
CAS:
355025-24-0
MF:
C23H23ClN2O5S
Structure:
Chemical Name:
Diphemanil Methylsulfate
CAS:
62-97-5
MF:
C20H24N.CH3O4S
Structure:
Chemical Name:
Salirasib
CAS:
162520-00-5
MF:
C22H30O2S
Structure:
Chemical Name:
RO-31-8220
CAS:
138489-18-6
MF:
C25H23N5O2S